Conference Day One

Day 2

Expand All Sessions [+] Collapse All Sessions [-]

8:15 AM IQPC Welcome


8:25 AM Chairperson's Welcome

Andrew Mcdougall , Deputy Editor, Cometics Design Europe

Andrew Mcdougall
Deputy Editor
Cometics Design Europe

A Spotlight on Labelling and Safety Regulations
8:40 AM Case Study: An SME’s Perspective on Maximising Organic Growth in the EU Market

Colleen Harte , Founder & Creative Director, Lucy Annabella Organics

  • From home-made to global: the underlying reasons for tackling EU Cosmetic Compliance
  • Cost-efficient routes of tackling the challenges of cosmetic compliance as an SME
  • The regulatory  obstacles encountered and how we overcame them within budget
  • Maximising growth in the EU market whilst saving costs
Colleen Harte
Founder & Creative Director
Lucy Annabella Organics

9:20 AM Understanding the Guidance for Cosmetic Labelling and Save Costs by Meeting Minimum Standards in the EU Market

Elizabeth Colsen , Head of Product Legislation Compliance, McBride

  • From font to function: underlining key labelling principles to facilitate efficient product launch
  • Warning! A take on printing safety regulations to meet minimum standards and cut packaging costs
  • Example of submission: avoid hefty fines and product recall: best practices on implementing the design and content to comply with the EU Cosmetics Directive
  • Claims from an SME perspective: A brief look at "free-from" claims and the increased complexity presented to SMEs.
Elizabeth Colsen
Head of Product Legislation Compliance
McBride
  • Stressing the importance of claim substantiation to avoid scrutiny from the FTC and FDA
  • Cost-effective practices for acquiring proof for specific claims
  • How will predicted trends for the FTC influence cosmetic label marketing?
  • Un-intentional drug claims: how to avoid costly mistakes
Angela Diesch
Shareholder
Kronick (KTMG)

11:10 AM Capitalise on Cosmetic Labelling by Streamlining Procedures to Comply with Legislation Whist Maximising on Marketing across the Globe

Sudhir Sawarkar , Regional Quality & Regulatory Affairs, Dabur International Ltd

  • Identifying current marketing requirements across the key market players: EU, Middle East, Canada & the US
  • In depth comparison of cosmetic legislations across  bench mark geographical regions including EU, US & Canada.
  • Understanding the role of consumer perception in terms of safety and efficacy impacting cosmetic labelling
  • Exploring the nanomaterial legislation in EU and US and its monetary impacts on the cosmetic trade
Sudhir Sawarkar
Regional Quality & Regulatory Affairs
Dabur International Ltd

11:45 AM Meet the Experts – Round Table Event

Presenting only the hottest topics surrounding global compliance, each table is dedicated to the pressing questions in specific regions. Put on your networking cap, share information and share best practice with your peers and our expert speaker panel members, who will lead the discussion. You select which roundtables are most suitable to you and join the discussion. You may move freely between the roundtables to ensure you get the most out of this organised networking session.

Table 1

Angela Diesch
Shareholder
Kronick (KTMG)

Table 2

South Africa: Underlining the Key Legislation & Regulation and its Impact on Your Cosmetic Products

Barry Podd , Former Associate Director of Global Regulatory Affairs, Kimberly Clark

Barry Podd
Former Associate Director of Global Regulatory Affairs
Kimberly Clark

Table 3

India and Africa: A Closer Look at the regulatory Challenges & Translating this to Business Opportunity

Sudhir Sawarkar , Regional Quality & Regulatory Affairs, Dabur International Ltd

Sudhir Sawarkar
Regional Quality & Regulatory Affairs
Dabur International Ltd

Table 4

Key focus on EU product registration: comply with the recent legislation

Tamsin Worrad , Senior Regulatory Affairs Officer, Teva Pharmaceuticals

Tamsin Worrad
Senior Regulatory Affairs Officer
Teva Pharmaceuticals

12:30 PM Networking Lunch

EU Cosmetic Directive vs FDA and the US Market
1:30 PM An Insight to US Regulation: Understanding the FDA's Priorities for 2015/2016 to Ensure Efficient Practices

Linda M Katz , Director, Office of Cosmetics & Colors, FDA

  • An introduction to the FDA and the priorities for 2015/2016
  • An insight to the US process: clarifying the regulations in the US
  • Tackling the perceived  ambiguity in US regulation: addressing the grey area
  • A look at common mistakes in cosmetic submissions and ways to combat them

Linda M Katz
Director, Office of Cosmetics & Colors
FDA

2:10 PM Case Study: Preventing Product Recall by Deconstructing the Complexity of US Compliance

Antonia Burrell , Founder & Managing Director, Antonia Burrell

  • An in depth look at the US Market and the complex legislation it presents
  • Preparing your product launch for maximum ROI: gaining an insight into an US launch
  • The regulatory challenges we faced when launching our product in to the US
  • Exploring the grey area: how do you deal with the intersecting area of drugs, OTC and cosmetics?
  • Best practice for launching into the US whilst preventing product recall

Antonia Burrell
Founder & Managing Director
Antonia Burrell

2:50 PM Accelerating Product Launch by Understanding the Requirements of the FTC

Serena Viswanathan , Assistant Director, Federal Trade Commission

  • An introduction to the FTC and the role we play in Cosmetic Legislation
  • An insight to the US process: clarifying the regulations in the US
  • Tackling the perceived  ambiguity in US regulation: addressing the grey area
  • A look at common mistakes in cosmetic submissions and ways to combat them
Serena Viswanathan
Assistant Director
Federal Trade Commission
  • Highlighting the legislative differences between over the counter drugs and cosmetics to prevent scrutiny from health authorities 
  • Exploring the grey area: how do you deal with the intersecting area of drugs and cosmetics? 
  • Preparing your case in line with health authority regulations should your product come under investigation
  • Cosmetics vs medical devices: touching on ambiguous legislation
  • A glance at the latest changes in US legislation and the impact this has on borderline cosmetics
Tamsin Worrad
Senior Regulatory Affairs Officer
Teva Pharmaceuticals
  • The impact of the Sunscreen Innovation Act in the US
  • The ongoing challenges of UV filters in the EU Market
  • Underlining the ingredient review process in the EU
  • A closer look at the challenges of trace impurities
  • Cosmetic Ingredient Suppliers supporting cosmetic manufacturers to ensure compliant products in the EU
Ellen Pfrommer
Head of Regulatory & Product Stewardship
BASF
  • Deconstructing the CARB consumer product emissions survey to understand what is expected
  • Exploring how CARB data is used and the impact this has on product compliance
  • Limiting the impacts of product recall by developing strategies to tackle Californian Legislation
  • A look at the consequences and results of submission and how to overcome the regulatory challenges associated
Raoul Perfitt
Managing Director
Herb UK

6:00 PM Chairman’s Summary

Andrew Mcdougall , Deputy Editor, Cometics Design Europe

Andrew Mcdougall
Deputy Editor
Cometics Design Europe